The groundbreaking rise of Viagra presented a considerable prospect for the market, but its patent has lapsed , creating a intricate landscape. Off-brand versions have flooded the arena, eroding sales and putting pressure on profit percentages . While major healthcare companies hold a stake in this sector , the outlook looks unclear by fierce rival